glp-1 medications market 2025 Trends and Global Forecasts Report 2025: A Eli Lilly's 2025 GLP-1 Sales
Description
80 Outside of the context of type 2 diabetes, liraglutide has proven successful in causing significant weight loss when administered over 20 weeks to obese, non-diabetic patients
Bone 37 (6), 759769
Conversely, some people experience a brief period of looser stools as the digestive system readjusts to faster transit times
While GIP doesnt slow gastric emptying like GLP-1 does, it still affects gut function
Physical activity may help manage GLP-1 side effects
